A Study of Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Hoffmann-La Roche
Related studies linked through entity extraction aliases.
A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370)
- Status
- COMPLETED
- Phase
- PHASE3
Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)
- Status
- COMPLETED
- Phase
- N/A
An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)
- Status
- COMPLETED
- Phase
- PHASE4
A Pharmacokinetics, Pharmacodynamics and Safety Study of Warfarin in Combination With Tamiflu (Oseltamivir)
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Erlotinib (Tarceva) in Participants With Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT)
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
- Status
- TERMINATED
- Phase
- PHASE3
A Retrospective, Observational Registry of Participants With Avian Influenza Infection
- Status
- COMPLETED
- Phase
- N/A
Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE3